Interrogating host immunity to predict treatment response in inflammatory bowel disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interrogating host immunity to predict treatment response in inflammatory bowel disease
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 17, Issue 1, Pages 9-20
Publisher
Springer Science and Business Media LLC
Online
2019-11-26
DOI
10.1038/s41575-019-0228-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
- (2019) Samuel P. Costello et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
- (2019) Bram Verstockt et al. EBioMedicine
- OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI
- (2019) W J Sandborn et al. Journal of Crohns & Colitis
- Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
- (2019) Matthias Friedrich et al. IMMUNITY
- Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
- (2019) Eirini Pantazi et al. Frontiers in Immunology
- Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease
- (2018) Heike Schmitt et al. GUT
- Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
- (2018) Renaud Gaujoux et al. GUT
- Reversal of Intestinal Failure in Children With Tufting Enteropathy Supported With Parenteral Nutrition at Home
- (2018) Iona Ashworth et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
- (2018) Tanbeena Imam et al. Frontiers in Immunology
- Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
- (2017) Bruce E. Sands et al. GASTROENTEROLOGY
- Safety and Efficacy of ABT-494 (Upadacitinib), an Oral Jak1 Inhibitor, as Induction Therapy in Patients with Crohn's Disease: Results from Celest
- (2017) William J. Sandborn et al. GASTROENTEROLOGY
- Molecular imaging of mucosal α4β7 integrin expression with the fluorescent anti-adhesion antibody vedolizumab in Crohn’s disease
- (2017) Timo Rath et al. GASTROINTESTINAL ENDOSCOPY
- Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
- (2017) Julian Panés et al. GUT
- Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
- (2017) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2017) Sudarshan Paramsothy et al. Journal of Crohns & Colitis
- Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
- (2017) Séverine Vermeire et al. LANCET
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
- (2017) Brian G Feagan et al. LANCET
- Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
- (2017) Subra Kugathasan et al. LANCET
- Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
- (2017) Katrina M de Lange et al. NATURE GENETICS
- Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- (2017) Nathaniel R West et al. NATURE MEDICINE
- Current and emerging therapeutic targets for IBD
- (2017) Markus F. Neurath Nature Reviews Gastroenterology & Hepatology
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Genomics in Inflammatory Bowel Disease
- (2017) Holm H. Uhlig et al. TRENDS IN GENETICS
- Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants
- (2017) Lam C. Tsoi et al. Nature Communications
- Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn’s Disease
- (2016) Grant E Barber et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Stem cell transplantation for tetratricopeptide repeat domain 7A deficiency: long-term follow-up
- (2016) J. Kammermeier et al. BLOOD
- Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
- (2016) Gaik W. Tew et al. GASTROENTEROLOGY
- Fungal microbiota dysbiosis in IBD
- (2016) Harry Sokol et al. GUT
- Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab
- (2016) Kimberly A. Harris et al. INFLAMMATORY BOWEL DISEASES
- mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
- (2016) Feidi Chen et al. JOURNAL OF IMMUNOLOGY
- An essential role for the IL-2 receptor in Treg cell function
- (2016) Takatoshi Chinen et al. NATURE IMMUNOLOGY
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
- (2016) Ulrike Billmeier et al. WORLD JOURNAL OF GASTROENTEROLOGY
- T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine
- (2016) Thomas Krausgruber et al. Nature Communications
- Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease
- (2016) Uri Kopylov et al. Therapeutic Advances in Gastroenterology
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
- (2015) Nick Powell et al. GASTROENTEROLOGY
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease
- (2015) Stephanie M. Slevin et al. INFLAMMATORY BOWEL DISEASES
- The biology of innate lymphoid cells
- (2015) David Artis et al. NATURE
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
- (2015) Jimmy Z Liu et al. NATURE GENETICS
- The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD
- (2015) Rimma Goldberg et al. Nature Reviews Gastroenterology & Hepatology
- Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
- (2015) B. Lo et al. SCIENCE
- Standardized Recording of Parameters Related to the Natural History of Inflammatory Bowel Disease: From Montreal to Paris
- (2014) Jeffrey S. Hyams DIGESTIVE DISEASES
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
- (2014) Holm H. Uhlig et al. GASTROENTEROLOGY
- Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific
- (2014) Siew C Ng et al. GUT
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- iPOP Goes the World: Integrated Personalized Omics Profiling and the Road toward Improved Health Care
- (2013) Jennifer Li-Pook-Than et al. CHEMISTRY & BIOLOGY
- Absence of a role for interleukin-13 in inflammatory bowel disease
- (2013) Paolo Biancheri et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- 52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
- (2013) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Whole-exome sequencing identifies tetratricopeptide repeat domain 7A ( TTC7A ) mutations for combined immunodeficiency with intestinal atresias
- (2013) Rui Chen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TTC7A mutations disrupt intestinal epithelial apicobasal polarity
- (2013) Amélie E. Bigorgne et al. JOURNAL OF CLINICAL INVESTIGATION
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
- (2013) Mehmet Coskun et al. PHARMACOLOGICAL RESEARCH
- The Age of Gene Discovery in Very Early Onset Inflammatory Bowel Disease
- (2012) Aleixo M. Muise et al. GASTROENTEROLOGY
- Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy
- (2012) Daniel Kotlarz et al. GASTROENTEROLOGY
- The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells
- (2012) Nick Powell et al. IMMUNITY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis
- (2012) Clémentine Perrier et al. INFLAMMATORY BOWEL DISEASES
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- The gut microbiota in IBD
- (2012) Chaysavanh Manichanh et al. Nature Reviews Gastroenterology & Hepatology
- Role of the Commensal Microbiota in Normal and Pathogenic Host Immune Responses
- (2011) Dan R. Littman et al. Cell Host & Microbe
- Recent Insights Into the Genetics of Inflammatory Bowel Disease
- (2011) Judy H. Cho et al. GASTROENTEROLOGY
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- (2011) S. Vermeire et al. GUT
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
- (2011) Ashutosh Chaudhry et al. IMMUNITY
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
- (2011) Alessandra Geremia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intestinal homeostasis and its breakdown in inflammatory bowel disease
- (2011) Kevin J. Maloy et al. NATURE
- Inflammatory Skin and Bowel Disease Linked toADAM17Deletion
- (2011) Diana C. Blaydon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
- (2010) Matthias Jürgens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
- (2010) T. T. MACDONALD et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection
- (2010) Miguel Regueiro et al. INFLAMMATORY BOWEL DISEASES
- Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
- (2010) Sofia Buonocore et al. NATURE
- RNA sequencing: advances, challenges and opportunities
- (2010) Fatih Ozsolak et al. NATURE REVIEWS GENETICS
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
- (2009) L. Rovedatti et al. GUT
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
- (2009) Erik-Oliver Glocker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
- (2008) Jennifer Jones et al. Clinical Gastroenterology and Hepatology
- IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
- (2008) T Kobayashi et al. GUT
- Analysis of bacterial bowel communities of IBD patients: What has it revealed?
- (2008) Harry Sokol et al. INFLAMMATORY BOWEL DISEASES
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More